Stoke Therapeutics, Inc. Property, Plant and Equipment, Gross
Stoke Therapeutics, Inc. (STOK) had Property, Plant and Equipment, Gross of $13.29 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-16
- 2025-12-31: Property, Plant and Equipment, Gross $13.29M.
- 2024-12-31: Property, Plant and Equipment, Gross $12.76M.
- 2023-12-31: Property, Plant and Equipment, Gross $12.49M.
- 2022-12-31: Property, Plant and Equipment, Gross $10.88M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $13.29M 10-K · filed 2026-03-16 |
| 2024-12-31 | $12.76M 10-K · filed 2026-03-16 |
| 2023-12-31 | $12.49M 10-K · filed 2025-03-18 |
| 2022-12-31 | $10.88M 10-K · filed 2024-03-25 |
| 2021-12-31 | $6.80M 10-K · filed 2023-03-06 |
| 2020-12-31 | $4.37M 10-K · filed 2022-03-10 |
| 2019-12-31 | $3.33M 10-K · filed 2021-03-09 |
| 2018-12-31 | $1.57M 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |